Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh

Abstract

Background The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual associations between specific blood parameters and COVID-19 are not well understood. Here we aimed to assess the correlations between hematological parameters and the severity of COVID-19. Methods We included COVID-19 patients who were admitted to Evercare Hospital Ltd, Dhaka, Bangladesh, between November 10, 2020, to April 12, 2021, with a confirmed case of RT-PCR test. We recorded demographic information, clinical data, and routine hematological examination results of all COVID-19 patients. We performed statistical analyses and interpretation of data to compare severe COVID-19 patients (SCP) and non-severe COVID-19 patients (NSCP). Results The age and BMI of the admitted COVID-19 patients were 48.79±8.53 years and 25.82±3.75 kg/m2. This study included a total of 306 hospitalized COVID-19 patients. Among them, NSCP and SCP were 198 and 108, respectively. And we recorded 12 deaths from SCP. We observed the alterations of several hematological parameters between SCP and NSCP. Among them, we noticed the increased levels of C-reactive protein (CRP), d-dimer, and ferritin showed good indicative value to evaluate the severity of COVID-19. Also, there were positive correlations among these parameters. Moreover, we found correlations between the outcomes of COVID-19 patients with patient’s demographics and comorbid diseases. Conclusion Based on our results, CRP, d-dimer, and ferritin levels at admission to hospitals represent simple assessment factors for COVID-19 severity and the treatment decisions at the hospital setup. These blood parameters could serve as indicators for the prognosis and severity of COVID-19. Therefore, our study findings might help to develop a treatment protocol for COVID-19 patients at the hospital setup.

Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India

“…Several previous studies have shown that elderly patients and those with elevated D-dimer with multiple systemic comorbidities had severe COVID-19 infection [15,21,22]. In our study, diabetes mellitus, acute kidney injury on admission, and raised D-dimer levels were associated with severe infection.…”

Practical Risk Scoring System for Predicting Severity of COVID-19 Disease

“… 1 - 17 The association of worse outcomes with the variables accounted for by the JRSS makes sense from a pathogenicity and literature standpoint. 1 - 17 The variables accounted for have either been reported as risk factors in multiple prior studies or involve an organ system that would be directly affected by the SARS-CoV-2 infection. 1 - 17 One of the risk factors, ethnicity, may be a marker of worse prognosis due to its very strong and well documented non-biological association with social and health inequalities or discrimination within society at large.…”

The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study

“…Among 12,924,116 (99.9%) persons whose age was known, 55.0% were aged ≥50 years, 16.8% were aged 40–49 years, and 28.2.% were aged 18–39 years. 24,25 One study reported that information about the vaccine, social influences, and trust in the healthcare profession significantly influence people to vaccinate. 26,27 There is no question that the current COVID-19 vaccines are effective and safe.…”